check_circleStudy Completed
Erythema, Skin recovery
Bayer Identifier:
20505
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
A study to gain information how well dexpanthenol dermal spray helps the face skin to recover after cosmetic lasering
Trial purpose
In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery and reduction of skin redness after a dermatological procedure (non-ablative laser) on the face for treatment of fine wrinkles, scars, open pores and change of pigmentation.
After the dermatological procedure, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol dermal spray.
After the dermatological procedure, participants will return within 3 weeks for 4 visits to the study center to investigate the skin conditions such redness, irritation, softness and possible side effects. In addition, study participants will be asked about their general acceptance of dexpanthenol dermal spray.
Key Participants Requirements
Sex
FemaleAge
30 - 60 YearsTrial summary
Enrollment Goal
33Trial Dates
January 2019 - March 2019Phase
Phase 4Could I Receive a placebo
NoProducts
Bepantol® Derma Spray (BAY207543)Accepts Healthy Volunteer
YesWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Medcin Instituto da Pele | Sao Paulo, 06023-070, Brazil |
Primary Outcome
- Transepidermal water loss by TEWL probeThe transepidermal water loss (TEWL) is measured in g m2 h-1 with a Tewameter TM300.date_rangeTime Frame:Up to 23 days
- Dermic temperature by thermographic camera (FLIR T530sc)date_rangeTime Frame:Up to 23 days
Secondary Outcome
- Skin properties of the participantsInvestigators assess various skin properties of the participants with a questionnaire (each scored from 1 to 5), resulting in an overall efficacy score from 9 to 45 (a higher score represents higher efficacy).date_rangeTime Frame:Up to 23 days
- Treatment satisfactionParticipants assess their treatment satisfaction with a questionnaire consisting of 13 items (each item is scored from 1-5) resulting in a score range of 13 to 65 (a higher score represents better treatment satisfaction).date_rangeTime Frame:Up to 23 days
- Product evaluationParticipants assess their sensorial perception of different product attributes (e.g. smell, absorption) with a questionnaire consisting of 6 items (each item is scored from 1-5) resulting in a score range from 6 to 30 (a higher score represents higher product satisfaction).date_rangeTime Frame:Up to 23 days
- Number of adverse events by dermatological evaluationdate_rangeTime Frame:Up to 23 days
- Number of adverse events by ophthalmologic valuationdate_rangeTime Frame:Up to 23 days
- Severity of adverse events by dermatological evaluationdate_rangeTime Frame:Up to 23 days
- Severity of adverse events by ophthalmologic valuationdate_rangeTime Frame:Up to 23 days
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
RandomizedBlinding
N/AAssignment
Parallel AssignmentTrial Arms
2